Takuya Okada

Takuya Okada


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2020 in Cells
Verified
Journal Article
Open access
PDF file
SHShiori Hiramoto
Shiori Hiramoto
MTMaho Tsubota
Maho Tsubota
KYKaoru Yamaguchi
Kaoru Yamaguchi
KOKyoko Okazaki
Kyoko Okazaki
ASAya Sakaegi
Aya Sakaegi
Atsufumi KawabataAtsufumi Kawabata
Atsufumi Kawabata
Cystitis-related bladder pain involves RAGE activation by HMGB1, and increased Cav3.2 T-type Ca2+ channel activity by H2S, generated by upregulated cystathionine-γ-lyase (CSE) in mice treated with cyclophosphamide (CPA). We, thus, investigated possible crosstalk between the HMGB1/RAGE and CSE/H2S/Cav3.2 pathways in the bladder pain development. Bladder pain (nociceptive behavior/referred hyperalgesia) and immuno-reactive CSE expression in the bladder were determined in CPA-treated female mice. Cell signaling was analyzed in urothelial T24 and macrophage-like RAW264.7 cells. The CPA-induced bladder pain was abolished by pharmacological inhibition of T-type Ca2+ channels or CSE, and genetic deletion of Cav3.2. The CPA-induced CSE upregulation, as well as bladder pain was prevented by HMGB1 inactivation, inhibition of HMGB1 release from macrophages, antagonists of RAGE or P2X4/P2X7 receptors, and N-acetylcysteine, an antioxidant. Acrolein, a metabolite of CPA, triggered ATP release from T24 cells. Adenosine triphosphate (ATP) stimulated cell migration via P2X7/P2X4, and caused HMGB1 release via P2X7 in RAW264.7 cells, which was dependent on p38MAPK/NF-κB signaling and reactive oxygen species (ROS) accumulation. Together, our data suggest that CPA, once metabolized to acrolein, causes urothelial ATP-mediated, redox-dependent HMGB1 release from macrophages, which in turn causes RAGE-mediated CSE upregulation and subsequent H2S-targeted Cav3.2-dependent nociceptor excitation, resulting in bladder pain.

31 May 2023 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Suresh AwaleSuresh Awale
Suresh Awale
HBHayato Baba
Hayato Baba
NPNguyen Duy Phan
Nguyen Duy Phan
MKMin Jo Kim
Min Jo Kim
Juthamart ManeenetJuthamart Maneenet
Juthamart Maneenet
NTNaoki Toyooka
Naoki Toyooka

27 August 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YKYoshihito Kasanami
Yoshihito Kasanami
CIChihiro Ishikawa
Chihiro Ishikawa
TKTakahiro Kino
Takahiro Kino
MCMomoka Chonan
Momoka Chonan
NTNaoki Toyooka
Naoki Toyooka
Atsufumi KawabataAtsufumi Kawabata
Atsufumi Kawabata

25 January 2021 in Plants
Verified
Journal Article
Open access
PDF file
Sijia SunSijia Sun
Sijia Sun
MKMIN JO KIM
MIN JO KIM
DDDya Fita Dibwe
Dya Fita Dibwe
AOAshraf M. Omar
Ashraf M. Omar
SASirivan Athikomkulchai
Sirivan Athikomkulchai
Suresh AwaleSuresh Awale
Suresh Awale
Human pancreatic tumor cells have an intrinsic ability to tolerate nutrition starvation and survive in the hypovascular tumor microenvironment, the phenomenon termed as “austerity”. Searching for an agent that inhibits such tolerance to nutrient starvation and kills the pancreatic cancer cells preferentially in nutrient-starvation is a unique anti-austerity strategy in anti-cancer drug discovery. In this strategy, plant extracts and compounds are tested against PANC-1 human pancreatic cancer cell line under the conditions of nutrient-deprived medium (NDM) and nutrient-rich medium (DMEM), to discover the compounds that show selective cytotoxicity in NDM. Screening of twenty-five Thai indigenous medicinal plant extracts for their anti-austerity activity against the PANC-1 human pancreatic cancer cell line in nutrient deprived medium (NDM) resulted in the identification of four active plants, Derris scandens, Boesenbergia pandurata, Citrus hystrix, and Kaempferia parviflora, with PC50 values 0.5–8.9 µg/mL. K. parviflora extract also inhibited PANC-1 cancer cell colony formation. Phytochemical investigation of K. parviflora extract led to the isolation of fourteen compounds, including two polyoxygenated cyclohexanes (1 and 2), eleven flavonoids (3–13), and β-sitosterol (14). Stereochemical assignment of compound 1 was confirmed through X-ray analysis. All isolated compounds were tested for their preferential cytotoxicity against PANC-1 cells. Among them, 5-hydroxy-7-methoxyflavone (3) displayed the most potent activity with a PC50 value of 0.8 µM. Mechanistically, it was found to induce apoptosis in PANC-1 cell death in NDM as evident by caspase cleavage. It was also found to inhibit PANC-1 cancer cell colony formation in DMEM. Therefore, compound 3 can be considered as a potential lead compound for the anticancer drug development based on the anti-austerity strategy.

6 December 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MMMineyuki Mizuguchi
Mineyuki Mizuguchi
YNYusuke Nakagawa
Yusuke Nakagawa
KIKishin Inui
Kishin Inui
WKWakana Katayama
Wakana Katayama
YSYurika Sawai
Yurika Sawai
NTNaoki Toyooka
Naoki Toyooka

14 June 2023 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AKAtsushi Kato
Atsushi Kato
INIzumi Nakagome
Izumi Nakagome
MKMaki Kise
Maki Kise
KYKousuke Yoshimura
Kousuke Yoshimura
NTNobutada Tanaka
Nobutada Tanaka
NTNaoki Toyooka
Naoki Toyooka